Intelligent Bio Solutions Inc.
INBS· Nasdaq
INBSIntelligent Bio Solutions Inc.
Quarterly figures for Intelligent Bio Solutions Inc., with source filings when available.
28 quarters. Sep 30, 2019 to Jun 30, 2026. USD.
Intelligent Bio Solutions Inc. has filed its 10-Q within 38 to 44 days of period end across its last 8 quarters. The 10-K runs 46 to 84 days.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q4 2026derived | Jun 30, 2026 | Aug 19, 2026 · pre-market | Aug 19, 2026 | 50 d | 10-K | $1.15M | +35.8% | — | |
| Q3 2026 | Mar 31, 2026 | May 13, 2026 · after-hours | May 13, 2026 | 43 d | 10-Q | $1.06M | +45.5% | -$1.80 |
|---|
| Q2 2026 | Dec 31, 2025 | Feb 12, 2026 · pre-market | Feb 12, 2026 | 43 d | 10-Q | $896.77K | +47.6% | -$2.82 |
|---|
| Q1 2026 | Sep 30, 2025 | Nov 12, 2025 · after-hours | Nov 12, 2025 | 43 d | 10-Q | $1.11M | +27.5% | -$0.35 |
|---|
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Jun 30, 2025 | Aug 15, 2025 · after-hours | Aug 15, 2025 | 46 d | 10-K | $843.88K | +15.9% | — | |
| Q3 2025 | Mar 31, 2025 | May 13, 2025 · after-hours | May 13, 2025 | 43 d | 10-Q | $728.87K | −11.5% | -$4.41 | |
| Q2 2025 | Dec 31, 2024 | Feb 10, 2025 · after-hours | Feb 13, 2025 | 44 d | 10-Q | $607.49K | −20.5% | -$4.96 | |
| Q1 2025 | Sep 30, 2024 | Nov 7, 2024 · after-hours | Nov 7, 2024 | 38 d | 10-Q | $872.29K | +9.6% | -$0.70 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Jun 30, 2024 | Sep 9, 2024 · after-hours | Sep 18, 2024 | 80 d | 10-K | $727.82K | +452.2% | — | |
| Q3 2024 | Mar 31, 2024 | May 8, 2024 · after-hours | May 8, 2024 | 38 d | 10-Q | $823.80K | +80.2% | -$1.43 | |
| Q2 2024 | Dec 31, 2023 | Feb 9, 2024 · after-hours | Feb 9, 2024 | 40 d | 10-Q | $764.06K | +114.2% | -$2.07 | |
| Q1 2024 | Sep 30, 2023 | Nov 8, 2023 · after-hours | Nov 8, 2023 | 39 d | 10-Q | $796.09K | +155.7% | -$12.48 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Jun 30, 2023 | — | Aug 23, 2023 | 54 d | 10-K | $131.82K | — | — | |
| Q3 2023 | Mar 31, 2023 | — | May 11, 2023 | 41 d | 10-Q | $457.06K | +137.4% | -$68.67 | |
| Q2 2023 | Dec 31, 2022 | — | Feb 14, 2023 | 45 d | 10-Q | $356.68K | +100.6% | -$5.56 | |
| Q1 2023 | Sep 30, 2022 | Nov 9, 2022 · after-hours | Nov 14, 2022 | 45 d | 10-Q | $311.32K | — | -$1.62 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Jun 30, 2022 | Aug 31, 2022 · after-hours | Sep 22, 2022 | 84 d | 10-K | — | — | — | |
| Q3 2022 | Mar 31, 2022 | May 11, 2022 · pre-market | May 16, 2022 | 46 d | 10-Q | $192.50K | +461.4% | — | |
| Q2 2022 | Dec 31, 2021 | Feb 10, 2022 · after-hours | Feb 11, 2022 | 42 d | 10-Q | $177.79K | −37.2% | -$0.23 | |
| Q1 2022 | Sep 30, 2021 | — | Nov 12, 2021 | 43 d | 10-Q | — | — | -$0.10 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Jun 30, 2021 | — | Sep 16, 2021 | 78 d | 10-K | $1.61M | — | — | |
| Q3 2021 | Mar 31, 2021 | — | May 13, 2021 | 43 d | 10-Q | $34.29K | N/M | -$0.27 | |
| Q2 2021 | Dec 31, 2020 | — | Feb 12, 2021 | 43 d | 10-Q | $283.04K | N/M | -$0.23 | |
| Q1 2021 | Sep 30, 2020 | — | — | — | — | $55.43K | — | -$0.12 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Jun 30, 2020 | — | — | — | — | — | — | — | |
| Q3 2020 | Mar 31, 2020 | — | — | — | — | -$1.53K | — | -$0.01 | |
| Q2 2020 | Dec 31, 2019 | — | — | — | — | -$798.00 | — | -$0.22 | |
| Q1 2020 | Sep 30, 2019 | — | — | — | — | — | — | — | |
